Description
NSE notifies listing of commercial papers from 10 companies including Godrej Industries, Alembic Pharmaceuticals, NABARD, and others effective July 25, 2025.
Summary
NSE has notified the listing of privately placed commercial papers from 10 companies on the debt market segment effective July 25, 2025. The circular lists commercial papers with varying face values of ₹5 lakh each, issued at discounts, with maturity periods ranging from 2 to 5 months. Total securities listed include 95,000+ units across all issuers.
Key Points
- 10 companies’ commercial papers admitted to NSE debt market trading
- All securities have face value of ₹5,00,000 each
- Issuance dates: July 24-25, 2025
- Maturity periods range from September 2025 to December 2025
- Securities issued at discount to face value
- Effective trading date: July 25, 2025
Regulatory Changes
No regulatory changes introduced. This is a standard notification under Regulation 3.1.1 of NSE Debt Market (Trading) Regulations for admitting privately placed securities to trading.
Compliance Requirements
- Listed companies must comply with ongoing debt market regulations
- Securities will trade under designated security codes as specified in the annexure
- Standard debt market trading rules apply to all listed commercial papers
Important Dates
- Effective Date: July 25, 2025 (trading commencement)
- Allotment Dates: July 24-25, 2025
- Maturity Dates: Range from September 25, 2025 to December 30, 2025
Impact Assessment
Medium impact on debt market participants as this adds new short-term commercial paper options for trading. The listing provides additional liquidity instruments in the debt market segment. Companies benefit from having their commercial papers traded on the exchange platform, potentially improving secondary market liquidity for investors.
Impact Justification
Regular administrative listing notification affecting multiple companies' debt securities but no regulatory changes